Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base.
Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base.
复制标题
DOI:
10.1245/s10434-012-2321-7
复制
发表时间:
2012-09
影响因子:
3.7
通讯作者:
Chang GJ
中科院分区:
文献类型:
--
作者:
Hyngstrom JR;Hu CY;Xing Y;You YN;Feig BW;Skibber JM;Rodriguez-Bigas MA;Cormier JN;Chang GJ
We evaluated clinical features and survival outcomes among patients with signet ring and mucinous histologies of colorectal adenocarcinoma using data from the National Cancer Data Base (NCDB). Patients aged 18–90 years with colorectal adenocarcinoma diagnosed between 1998 and 2002 were identified from the NCDB. Site-stratified (colon vs rectum) survival analysis was performed using multivariate relative survival adjusted for multiple clinicopathologic and treatment variables. The study included 244,794 patients: 25,546 (10%) with mucinous, 2,260 (1%) with signet ring, and 216,988 (89%) with nonmucinous, non–signet ring adenocarcinoma. Mucinous and signet ring cancers were more frequently right-sided (60% and 62%, respectively) than were nonmucinous, non–signet ring adenocarcinomas (42%, P < .001). Signet ring histology was associated with a higher stage (P < .001), and 77.2% of signet ring tumors were high-grade lesions, compared with 20% of mucinous and 17% of non–signet ring, nonmucinous adenocarcinomas (P < .001). After adjustment for covariates, signet ring histology was independently associated with higher risk of death (HR 1.42, 95% confidence interval [CI] 1.33-1.51, and HR 1.57, CI 1.38-1.77, for tumors located in the colon and rectum, respectively). Mucinous tumors of the rectum (HR 1.22, CI 1.16-1.29), but not the colon (HR 1.03, CI 1.00-1.06), were associated with increased risk of death. Signet ring cell adenocarcinomas of the colon and rectum and mucinous adenocarcinomas of the rectum are associated with poorer survival. These aggressive histologic variants of colorectal adenocarcinoma should be targeted for research initiatives to improve outcomes.
登录
查看更多内容
影响因子:
3.7
作者:
Bilimoria KY;Stewart AK;Winchester DP;Ko CY
通讯作者:
Ko CY
影响因子:
3.7
作者:
Shin, Ui Sup;Yu, Chang Sik;Kim, Jin Cheon
通讯作者:
Kim, Jin Cheon
影响因子:
2.5
作者:
Mizushima, Tsunekazu;Nomura, Masaya;Nishida, Toshirou
通讯作者:
Nishida, Toshirou
影响因子:
6.1
作者:
Song Wu;Wu Sui-jing;Zhan Wen-hua
通讯作者:
Zhan Wen-hua
影响因子:
7.5
作者:
Sung, Chang Okh;Seo, Jin Won;Park, Cheol-Keun
通讯作者:
Park, Cheol-Keun